| Document |
Document Title |
|
JP5015409B2 |
The present invention relates to improved chelator conjugates with biological targeting molecules, suitable for forming metal complexes with radiometals. The radiometal complexes, especially with the radiometal 99mTc, are useful as radio...
|
|
JP5001480B2 |
Radiopharmaceutical compounds are disclosed. A tropane compound is linked through the N atom at the 8-position to a chelating ligand capable of complexing technetium or rhenium to produce a neutral labeled complex that selectively binds ...
|
|
JP4995571B2 |
The invention relates generally to biotin-containing compounds that are useful as imaging agents and drug-delivery agents. Another aspect of the invention relates to the aforementioned compounds chelated to a metal atom. In a preferred e...
|
|
JP4988159B2 |
Metal films are deposited with uniform thickness and excellent step coverage. Copper metal films were deposited on heated substrates by the reaction of alternating doses of copper(I) NN'-diisopropylacetamidinate vapor and hydrogen gas. C...
|
|
JP2012140424A |
To provide compounds that selectively bind to cells undergoing perturbations of the normal organization of cell plasma membranes.The compounds are represented by the structure as set forth in the formula (II), including pharmaceutically ...
|
|
JP4951798B2 |
The disclosure provides pendant fatty acid compounds for use in diagnostic imaging, (particularly the cardiovascular system), as well as kits comprised of the same. The disclosure also provides for a method administering a imaging agent ...
|
|
JP4951728B2 |
To provide a manufacturing method of a huge single crystal of a metal complex of an organic carboxylic acid useful as a gas adsorbent. The manufacturing method of the huge single crystal represented by general formula [I] comprises formi...
|
|
JP4947866B2 |
Chiral ligands and transition metal complexes based on such chiral ligands useful in asymmetric catalysis are disclosed. The chiral ligands include chiral C1-C6 TunaPhos ligands. The ruthenium TunaPhos complex reduces ketones to the corr...
|
|
JP4939937B2 |
Diarylethene-containing ligands and their coordination compounds are described. The ligands display photochromism with UV excitation, while the coordination compounds display photochromism with both excitation in the UV region and excita...
|
|
JP2012097097A |
To provide compounds which are effective as catalysts for dismutating superoxide.This invention relates to manganese or iron complexes of substituted, unsaturated heterocyclic pentaazacyclopentadecane ligands which catalytically dismutat...
|
|
JP2012511022A |
A compound that recognizes and binds to the CA-IX protein has Formula I, II, III, or IV. The compounds may include a radioactive element for radioimaging or therapeutic applications. Thus, pharmaceutical compositions may be prepared with...
|
|
JP2012511024A |
A compound that recognizes and binds to the CA-IX protein has Formula I, II, III, or IV. The compounds may include a radioactive element for radioimaging or therapeutic applications. Thus, pharmaceutical compositions may be prepared with...
|
|
JP2012067135A |
To provide a technetium or rhenium radio-labelled dopamine transporter (DAT) imaging agent which is capable of crossing the blood brain barrier and has a high binding affinity and selectivity for the DAT.A tropane compound is linked thro...
|
|
JP2012054571A |
To provide an organic electroluminescent device in which luminous efficiency is improved.In a light-emitting device including an anode, a cathode, and a luminous layer located between the anode and cathode, the luminous layer contains a ...
|
|
JP4897676B2 |
A method of immobilising a target molecule on a substrate, which comprises exposing the target molecule to the substrate in the presence of a metal complex, wherein the target molecule is an unmodified target molecule, and wherein the me...
|
|
JP4885354B2 |
Compositions that are chemical combination of porphyrins, chlorins, bacteriochlorins, and related tetra-pyrrolic compounds with radioactive elements such as Technetium<99>, Gadolinium, Indium<111> and radioactive iodine. When the element...
|
|
JP4885447B2 |
A binuclear organometallic complex enabling highly efficient phospholuminescence and an organic electroluminescent device using the same. The binuclear organometallic complex, which can be suitably used to form an organic layer of an org...
|
|
JP2012031161A |
To provide a metal complex having excellent gas occlusion capability and gas separating capability.The metal complex is constituted of isophthalic acid and the derivative of the same, metal ions such as magnesium ions, a calcium ions, zi...
|
|
JP2012503670A |
Novel radiopharmaceuticals that are useful in diagnostic imaging and therapeutic treatment of disease characterized by overexpression of seprase include complexes that contains a proline moiety and a radionuclide adapted for radioimaging...
|
|
JP4846199B2 |
One aspect of the invention relates to novel complexes of technetium (Tc) with various heteroaromatic ligands, e.g., pyridyl and imidazolyl ligands, and their use in radiopharmaceuticals for a variety of clinical diagnostic and therapeut...
|
|
JP2011258958A |
To provide a light emitting device in which a counter ion is substantially immobile so that light emission from the device is immediate.The light emitting device includes; an anode; a cathode; and a luminous layer located between the ano...
|
|
JP4837857B2 |
Chiral ligands and transition metal complexes based on such chiral ligands useful in asymmetric catalysis are disclosed. The chiral ligands include phospholanes, P,N ligands, N,N ligands, biphenols, and chelating phosphines. The ferrocen...
|
|
JP2011238936A |
To provide a light emitting device having a luminous layer including a metal complex suitable for a solution process.The light emitting device includes an anode 2, a cathode 5, a luminous layer 4 located between the anode and the cathode...
|
|
JP4796301B2 |
The present invention relates to compounds and related technetium and rhenium complexes thereof which are suitable for imaging or therapeutic treatment of tissues, organs, or tumors. In another embodiment, the invention relates the metho...
|
|
JP4716193B2 |
To provide a metal complex compound capable of being suitably used for manufacturing a metal-containing thin film by the CVD method and a method for preparing a metal-containing thin film. A metal complex compound comprising a beta-diket...
|
|
JP2009509320T5 |
|
|
JP2011516253T |
The present invention relates to a way at least a selected metal complex compound and 配 remove a stain and dirt of use and cloth as a child's oxidation catalyst, and a hard surface. At least hydrazide 配 which has an electron-attracti...
|
|
JP2011515346T |
A following formula, i. e., [L3MO3]nIt is how to compound a complex which を有 and they are inside of a formula, and L.3At least は三座配 expresses a child, M expresses metal chosen from Tc and Re, n is an electric charge of*2 to 1...
|
|
JP4667768B2 |
|
|
JP4666447B2 |
Novel metal complexes of tripoadal ligands are useful as catalysts to enhance the action of peroxygen compounds in washing, cleaning and disinfecting processes.
|
|
JP2011509304A |
Novel radiopharmaceuticals that are useful in diagnostic imaging and therapeutic treatment of disease characterized by over expression of CA-IX comprise a complex that contains a sulfonamide moiety which is capable of binding the active ...
|
|
JP2011051949A |
To provide a metal complex having excellent gas separation performance.The metal complex comprises: a dicarboxylic acid compound represented by general formula (I); at least one metal selected from metals that belong to periods 4 and 5 o...
|
|
JP4643259B2 |
The present invention relates to the use of metal complex compounds which have terpyridine ligands and contain at least one quaternized nitrogen atom as oxidation catalysts. The present invention relates also to formulations comprising s...
|
|
JP4639086B2 |
Provided is a composition for accelerating absorption of metals, comprising a metal-acidic amino acid chelate as an active ingredient. The composition of the present invention has therapeutic effects on prevention and treatment of variou...
|
|
JP4634932B2 |
A ligand represented by the formula (1): R1R2N-Q1-X-Q2-NR3R4 (1) wherein R1, R2, R3 and R4 are each the same or different and represent a group represented by the formula (2): wherein Q3 is an optionally substituted alkylene group, an op...
|
|
JP4629652B2 |
This invention relates to a novel crystal form of the 1:1 manganese (III) complex of N,N',N''tris[salicylideneaminoethyl]amine, a process for its preparation and the use thereof.
|
|
JP4611017B2 |
The invention provides novel amino acid compounds of use in detecting and evaluating brain and body tumors. These compounds combine the advantageous properties of α-aminoisobutyric acid (AIB) analogs namely, their rapid uptake and prolo...
|
|
JP4606579B2 |
A catalyst for the polymerisation of 1-olefins is disclosed, which comprises (1) a compound of Formula B wherein M is Fe[II], Fe[III], Co[I], Co[II], Co[III], Mn[I], Mn[II], Mn[III], Mn[IV], Ru[II], Ru[III] or Ru[IV]; X represents an ato...
|
|
JP4596778B2 |
Phosphorescent organometallic complexes comprising phenylquinolinato ligands are provided. High efficiency organic light emitting devices comprising these compounds are also described.
|
|
JP2010536799A |
The present invention provides novel bimetallic complexes and methods of using the same in the isoselective polymerization of epoxides. The invention also provides methods of kinetic resolution of epoxides. The invention further provides...
|
|
JP2010265245A |
To provide a material for separating a gas, having excellent capability of separating a gas. The metal complex includes a dicarboxylic acid compound (I) represented by formula (I); at least one species of metal selected from chromium, mo...
|
|
JP2008500717T5 |
|
|
JP2010209021A |
To provide a heteronuclear complex that enables more precise controlling of the arrangement of different species of noble metal, and a method of producing the same. There are provided a heteronuclear complex wherein at least one of aceti...
|
|
JP4549614B2 |
Catalyst systems useful for the polymerisation of 1-olefins are disclosed, which contain nitrogen-containing transition metal compounds comprising the skeletal unit depicted in Formula (B), wherein M is Fe[II], Fe[III], Ru[II], Ru[III] o...
|
|
JP2010202531A |
To provide a new optically active dimanganese complex.There is provided the new optically active dimanganese complex represented by formula (I) or (I') (wherein, R0 to R7 are each H, halogen, alkyl, or alkoxy; R2 and R3 may be bound to e...
|
|
JP4543169B2 |
To provide a thin film comprising an organic material that becomes semipermanent electro conductive by irradiating light, and a multi layer electro conductive film comprising a thin film of an organic material. The electro conductive fil...
|
|
JP4538797B2 |
Use of metal complex compounds of formula (1) and/or (1') [LnMemXp]zYq (1), [L'nMemXp]zYq (1'), wherein all substituents are as defined in the claims, as catalysts for oxidation reactions, and also novel metal complex compounds and novel...
|
|
JP2010180202A |
To provide a metal complex having an excellent gas-separating performance.This metal complex comprises a dicarboxylic acid compound in whose structure the carboxy groups are located at an angle of 120° to each other, such as an isophtha...
|
|
JP4522090B2 |
A photosensitizer complex of formula (I) MLX2 in which M is a transition metal selected from ruthenium, osmium, iron, rhenium and technetium; each X is a co-ligand independently selected from NCS-, Cl-, Br-, I-, CN-, H2O; pyridine unsubs...
|
|
JP4518242B2 |
|
